Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 09-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50,126 | 64,182 | 28,210 | 114,460 | 32,313 |
| Marketable Securities | 29,578 | 94,914 | 258,597 | 41,599 | 9,760 |
| Receivables | 27,350 | 408 | 223 | 349 | 85 |
| Inventories | 9,415 | 96 | 384 | 344 | 370 |
| Other current assets | 788 | 0 | 0 | 0 | 0 |
| TOTAL | $122,729 | $164,310 | $290,214 | $157,851 | $43,123 |
| Non-Current Assets | |||||
| PPE Net | 12,417 | 11,223 | 4,542 | 4,457 | 4,232 |
| Investments And Advances | 49,013 | 54,335 | 0 | 0 | 0 |
| Intangibles | 0 | 1,566 | 0 | 0 | 0 |
| Other Non-Current Assets | 460 | 521 | 95 | 34 | 16 |
| TOTAL | $61,890 | $67,645 | $4,637 | $4,491 | $4,247 |
| Total Assets | $184,619 | $231,955 | $294,851 | $162,342 | $47,371 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,432 | 2,305 | 1,733 | 3,851 | 4,759 |
| Accrued Expenses | 21,931 | 11,571 | 5,547 | 3,550 | 3,735 |
| TOTAL | $37,561 | $14,392 | $8,018 | $8,377 | $9,501 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 10,198 | 516 | 738 | 976 | 1,007 |
| Other Non-Current Liabilities | 3,081 | 3,149 | 0 | 0 | 0 |
| TOTAL | $4,081 | $4,149 | $879 | $1,688 | $1,795 |
| Total Liabilities | $41,642 | $18,541 | $8,897 | $10,065 | $11,296 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,988 | 17,023 | 16,982 | 14,150 | N/A |
| Common Shares | 174 | 170 | 169 | 141 | 119 |
| Retained earnings | -281,686 | -188,335 | -116,688 | -82,794 | -75,354 |
| Other shareholders' equity | -7,925 | -9,959 | 127 | 0 | 0 |
| TOTAL | $142,977 | $213,414 | $285,954 | $152,277 | $36,075 |
| Total Liabilities And Equity | $184,619 | $231,955 | $294,851 | $162,342 | $47,371 |